Standout Papers

A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis 2003 2026 2010 2018 933
  1. A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis (2003)
    David H. Miller, Omar Khan et al. New England Journal of Medicine

Immediate Impact

2 by Nobel laureates 25 from Science/Nature 98 standout
Sub-graph 1 of 17

Citing Papers

Structural basis of NINJ1-mediated plasma membrane rupture in cell death
2023 StandoutNature
Physiology and diseases of tissue-resident macrophages
2023 StandoutNature
14 intermediate papers

Works of Michele Libonati being referenced

Randomized multicenter trial of natalizumab in acute MS relapses
2004
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
2003 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Michele Libonati 440 619 212 414 8 1.2k
Laura R. Tranquill 695 456 239 219 17 1.1k
Magdalena J. Glogowska 533 396 495 186 15 1.4k
Koenraad Gijbels 544 202 293 231 9 1.3k
Cheryl M. Bergman 859 251 193 325 9 1.2k
Itzhack Mendel 821 434 185 230 10 1.2k
G Hermans 935 497 392 277 9 1.5k
Holger Babbe 701 605 248 217 8 1.2k
Uschi Brehm 521 738 194 136 7 1.1k
Robert Medaer 1070 603 162 163 24 1.4k
H. Wekerle 767 144 175 140 21 1.1k

All Works

Loading papers...

Rankless by CCL
2026